Drugs containing valsartan are used to treat patients with high blood pressure to help prevent heart attacks and stroke. The Ministry of Food and Drug Safety banned the import and sale of 115 hypertension drugs out of fear that they might contain carcinogenic ingredients.
Valsartan, a drug widely used to control blood pressure is being recalled in several countries around the world because of its chemical ingredient possibly linking to cancer.
The ban followed a recall order made by the European Medicines Agency last week after it found NDMA in Valsartan made by Zhejiang Huahai Pharmaceutical in China.
The recall was first issued on July 9th by the federal agency. The company says that "no other Sandoz or Novartis products, even those that may contain valsartan, are affected by the recall". The agency also said that everyone that takes medication which contains valsartan should continue taking it unless their doctor or pharmacist tells them to stop.
In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) is working with pharmacies to recall the affected medicines but have also stated the importance of patients continuing their treatment but to seek advice from a healthcare professional immediately.
This Is the Most Tender Photo of the World Cup So Far
Overall, it's not a surprise Belgium is favored, as it has looked like the better team in this tournament and has more talent. He will be crucial in the final against Croatia taking on the unsafe Perisic and Rebic but is capable of handling the task.
Prince Louis Christening: Enjoy All The Pics Of The Royal Family
Duchess of Cambridge Kate Middleton wore a white structured Alexander McQueen dress with a Jane Taylor headpiece. Prince Harry has purchased a first edition of the famous novel, Winnie-the-Pooh, for £8,000.
Justice Dept reopens investigation into Emmett Till’s lynching murder
But Parker says the discussion likely occurred after the release of a book that raised questions about the Till case a year ago . The government hasn't specified if any new charges will be added, or if the prosecution will bring a case to anyone involved.
The medications contain the ingredient "valsartan" which was found in some products to have an impurity called N-Nitrosodimethylamine, a potential human carcinogen that could cause cancer with long-term exposure.
While the review is underway, national authorities across the European Union are recalling medicines containing valsartan supplied by Zhejiang Huahai.
On Saturday, the Health Insurance Review & Assessment Service revised its Drug Utilization Review, a computerized pharmaceutical review system that oversees prescriptions, to display an on-screen warning when doctors try to prescribe a banned drug on their computers.
"It is vital that patients taking valsartan medication affected by this recall do not stop taking their medication abruptly and consult with their doctor or healthcare professional as soon as possible for alternative treatment", according to the Inspectorate of Health.